Metabolic Parameters as Predictors for Progression Free and Overall Survival of Patients with Metastatic Colorectal Cancer

por Nemeth, Zsuzsanna, Wijker, Wouter, Lengyel, Zsolt, Hitre, Erika, Borbely, Katalin
Publicado 2020

High Neutrophil-To-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) Are Markers of Longer Survival After Metastasectomy of Patients With Liver-Only Metastasis of...

por Polk, Nándor, Budai, Barna, Hitre, Erika, Patócs, Attila, Mersich, Tamás
Publicado 2022

Corrigendum: High Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) are Markers of Longer Survival After Metastasectomy of Patients With Liver-Only...

por Polk, Nándor, Budai, Barna, Hitre, Erika, Patócs, Attila, Mersich, Tamás
Publicado 2022

Effects of the lactase 13910 C/T and calcium-sensor receptor A986S G/T gene polymorphisms on the incidence and recurrence of colorectal cancer in Hungarian population

por Bácsi, Krisztián, Hitre, Erika, Kósa, János P, Horváth, Henrik, Lazáry, Áron, Lakatos, Péter L, Balla, Bernadett, Budai, Barna, Lakatos, Péter, Speer, Gábor
Publicado 2008

Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients

por Lakatos, Peter Laszlo, Hitre, Erika, Szalay, Ferenc, Zinober, Kerstin, Fuszek, Peter, Lakatos, Laszlo, Fischer, Simon, Osztovits, Janos, Gemela, Orsolya, Veres, Gabor, Papp, Janos, Ferenci, Peter
Publicado 2007

SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer

por Komlósi, Viktor, Hitre, Erika, Pap, Éva, Adleff, Vilmos, Réti, Andrea, Székely, Éva, Bíró, Anna, Rudnai, Péter, Schoket, Bernadette, Müller, Judit, Tóth, Béla, Ottó, Szabolcs, Kásler, Miklós, Kralovánszky, Judit, Budai, Barna
Publicado 2010

Cabozantinib for previously treated radioiodine‐refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC‐311 trial

por Brose, Marcia S., Robinson, Bruce G., Sherman, Steven I., Jarzab, Barbara, Lin, Chia‐Chi, Vaisman, Fernanda, Hoff, Ana O., Hitre, Erika, Bowles, Daniel W., Sen, Suvajit, Oliver, Jennifer W., Banerjee, Kamalika, Keam, Bhumsuk, Capdevila, Jaume
Publicado 2022

Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study

por Kuemmel, Sherko, Tondini, Carlo A., Abraham, Jacinta, Nowecki, Zbigniew, Itrych, Bartosz, Hitre, Erika, Karaszewska, Bogusława, Juárez-Ramiro, Alejandro, Morales-Vásquez, Flavia, Pérez-García, Jose Manuel, Cardona-Huerta, Servando, Monturus, Estefania, Sequi, Marco, Restuccia, Eleonora, Benyunes, Mark, Martín, Miguel
Publicado 2021

Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma

por Van Cutsem, Eric, Tempero, Margaret A., Sigal, Darren, Oh, Do-Youn, Fazio, Nicola, Macarulla, Teresa, Hitre, Erika, Hammel, Pascal, Hendifar, Andrew E., Bates, Susan E., Li, Chung-Pin, Hingorani, Sunil R., de la Fouchardiere, Christelle, Kasi, Anup, Heinemann, Volker, Maraveyas, Anthony, Bahary, Nathan, Layos, Laura, Sahai, Vaibhav, Zheng, Lei, Lacy, Jill, Park, Joon Oh, Portales, Fabienne, Oberstein, Paul, Wu, Wilson, Chondros, Dimitrios, Bullock, Andrea J.
Publicado 2020